We are pleased to announce that ACTS has joined St. Peter’s Health Partners Medical Associates.
SPHPMA is one of the Capital Region’s largest multi-specialty physician groups with more than 850 physicians and advanced practitioners in more than 100 locations.
To learn more about SPHPMA, click here.
ABOUT US
Albany Cardiothoracic Surgeons is the oldest heart surgery practice dedicated to cardiothoracic surgery in the Capital District. Our history is a 50-year long tradition of working as a coordinated team to provide expert, high quality, compassionate cardiothoracic surgical care. We serve residents in a broad tri-state area, centered in the Capital District of New York.
Albany Cardiothoracic Surgeons is the exclusive provider of cardiac surgery at St. Peters Hospital in Albany, New York. Our services range from the latest techniques of minimally invasive surgery to the most complex and difficult surgery requiring combinations of traditional and advanced techniques. Our surgical results have surpassed both the state and national standards.
Please see our contact information for office locations and directions.
OUR MISSION
- We treat all persons with dignity, hospitality and compassion, calling forth their best human potential.
- We provide comprehensive services that support healthy communities, including quality medical care with holistic approaches to healing body, mind and spirit.
- We care for and strengthen the ministry and all resources entrusted to us.
- We advocate for accessible health care and quality of life for all, especially those who are poor.
- We respond with courage and integrity to needs for services in a rapidly changing health care environment.
LATEST CARDIOLOGY NEWS
(MedPage Today) -- The investigational triple agonist retatrutide substantially improved glycemic control and body weight in adults with obesity and type 2 diabetes, a phase III trial showed.
Among 1,152 participants, average percentage of body...
(MedPage Today) -- The FDA approved the Autus Size-Adjustable Valve for surgical pulmonary valve replacement in children with congenital heart disease, the agency announced on Thursday.
The Autus valve marks the first such valve dedicated to pediatric...
(MedPage Today) -- The FDA expanded its approval of mavacamten (Camzyos) to include children with symptomatic obstructive hypertrophic cardiomyopathy (HCM).
Mavacamten thus becomes the first cardiac myosin inhibitor indicated for pediatric patients...
(MedPage Today) -- Orforglipron (Foundayo) was able to claim cardiovascular safety based on the ACHIEVE-4 trial, though heart benefits remain unproven.
Among adults with type 2 diabetes and obesity or overweight at risk for increased cardiovascular...
(MedPage Today) -- In upstate New York, patients risk losing care as Ellis Medicine and St. Peter's Health Partners battle in court over the non-compete agreements of 27 cardiologists. (CBS6)
American guidelines were updated regarding perioperative...